Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

COVID Surg Collaborative

doi:10.1093/bjsopen/zrab131

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

COVID Surg Collaborative

Research output: Contribution to journal › Letter › peer-review

45 Downloads (Pure)

Abstract

There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

Original language	English
Article number	zrab131
Number of pages	15
Journal	BJS Open
Volume	5
Issue number	6
DOIs	https://doi.org/10.1093/bjsopen/zrab131
Publication status	Published - 8 Jan 2022

Bibliographical note

Funding:
National Institute for Health Research (NIHR) Global Health Research Unit grant (NIHR 16.136.79) using UK aid from the UK government to support global health research, Association of Coloproctology of Great Britain and Ireland, Bowel & Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or UK Department of Health and Social Care.

Keywords

BCG Vaccine
COVID-19
Humans
SARS-CoV-2
Vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjsopen/zrab131Licence: Creative Commons: Attribution (CC BY)

TabiriS2022ImpactFinal published version, 227 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{b0fcdb3ecbee4c4eb792677cf770dbcf,

title = "Impact of Bacillus Calmette-Gu{\'e}rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection",

abstract = "There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.",

keywords = "BCG Vaccine, COVID-19, Humans, SARS-CoV-2, Vaccination",

author = "{COVID Surg Collaborative} and Paul Nankivell and Aneel Bhangu and Neil Sharma",

note = "Funding: National Institute for Health Research (NIHR) Global Health Research Unit grant (NIHR 16.136.79) using UK aid from the UK government to support global health research, Association of Coloproctology of Great Britain and Ireland, Bowel & Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or UK Department of Health and Social Care.",

year = "2022",

month = jan,

day = "8",

doi = "10.1093/bjsopen/zrab131",

language = "English",

volume = "5",

journal = "BJS Open",

issn = "2474-9842",

publisher = "Wiley Open Access",

number = "6",

}

TY - JOUR

T1 - Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

AU - COVID Surg Collaborative

AU - Nankivell, Paul

AU - Bhangu, Aneel

AU - Sharma, Neil

N1 - Funding: National Institute for Health Research (NIHR) Global Health Research Unit grant (NIHR 16.136.79) using UK aid from the UK government to support global health research, Association of Coloproctology of Great Britain and Ireland, Bowel & Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or UK Department of Health and Social Care.

PY - 2022/1/8

Y1 - 2022/1/8

N2 - There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

AB - There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

KW - BCG Vaccine

KW - COVID-19

KW - Humans

KW - SARS-CoV-2

KW - Vaccination

U2 - 10.1093/bjsopen/zrab131

DO - 10.1093/bjsopen/zrab131

M3 - Letter

C2 - 35022673

SN - 2474-9842

VL - 5

JO - BJS Open

JF - BJS Open

IS - 6

M1 - zrab131

ER -

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this